Medical affairs grantmaking has always required rigorous governance, documentation, and cross-functional coordination. What’s changed is the pace of innovation. Therapies are advancing faster, scientific engagement is rising, and medical affairs teams are being asked to operate with more speed across new products, geographies, and program structures while maintaining strict transparency and control.
This whitepaper outlines why legacy grantmaking models are breaking down and what modern operating model infrastructure looks like in practice. You’ll learn the strategic shifts medical affairs grantmakers need to implement to reduce friction, strengthen auditability, and build the kind of governed agility that keeps programs moving under real-world pressure.
Inside, you’ll learn how to:
- Understand the three core program types shaping medical affairs grantmaking today
- Identify where legacy workflows collapse, as they slow reviews, weaken audit trails, and increase burden on staff
- Implement five strategic transformations for faster, better-governed grant operations
- See what modernization looks like through real-world examples from Sanofi and Novartis
- Build toward governed agility with independence, transparency, and measurable program value
Ready to modernize your grantmaking operation?
Download the whitepaper to learn how medical affairs teams can increase speed and visibility while protecting compliance and independence.
